5PSQ-020 评估艾普科瑞他单抗-bysp对滤泡性B淋巴瘤患者的疗效和安全性：病例报告

{"title":"5PSQ-020 评估艾普科瑞他单抗-bysp对滤泡性B淋巴瘤患者的疗效和安全性：病例报告","authors":"M. Martinez, P. Rodriguez, R. Moron, J. Cabeza, G. Rodriguez","doi":"10.1136/ejhpharm-2024-eahp.354","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":107680,"journal":{"name":"Section 5: Patient safety and quality assurance","volume":"11 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"5PSQ-020 Evaluation of the efficacy and safety of epcoritamab-bysp in patients with follicular B lymphoma: a case report\",\"authors\":\"M. Martinez, P. Rodriguez, R. Moron, J. Cabeza, G. Rodriguez\",\"doi\":\"10.1136/ejhpharm-2024-eahp.354\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":107680,\"journal\":{\"name\":\"Section 5: Patient safety and quality assurance\",\"volume\":\"11 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 5: Patient safety and quality assurance\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2024-eahp.354\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 5: Patient safety and quality assurance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-eahp.354","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}